REFERENCES
- Bettini R., Castellani P. L., Santi P., Massimo G., Peppas N. A., Colombo P. Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rate. J. Control. Release. 2001; 70: 383–391, [INFOTRIEVE], [CSA]
- Brazel C. S., Peppas N. A. Modeling of drug release from swellable polymers. Eur. J. Pharm. Biopharm. 2000; 49: 47–58, [INFOTRIEVE], [CSA], [CROSSREF]
- www.pharmabiz.com/articledetnews.asp?articleid=16723§ionid=50&z=y Chikhalikar K., & Moorkath, S. (2003). Carbopol polymers: A versatile range of polymers for pharmaceutical applications. from PHARMABIZ.com.
- Efentakis M., Vlachou M., Choulis N. H. Effects of excipients on swelling and drug release from compressed matrices. Drug Dev. Ind. Pharm. 1997; 23: 107–112, [CSA]
- Espinoza R., Villafuerte L. Influence of admixed lactose on pelanserin hydrochloride release from hydroxypropyl methylcellulose matrix tablets. Pharm. Acta Helv. 1999; 74: 65–71, [CSA], [CROSSREF]
- Holgado M. A., Caraballo I., Alvarez-Fuentes J., Fernández-Hervás M. J., Fernández-Arévalo M., Rabasco A. M. Influence of diluents and manufacturing method on the in vitro dissolution of carteolol hydrochloride matrix tablets. Int. J. Pharm. 1995; 118: 151–160, [CSA], [CROSSREF]
- Katzhendler I., Hoffman A., Goldberger A., Friedman M. Modeling of drug release from erodible tablets. J. Pharm. Sci. 1997; 86(1)110–115, [INFOTRIEVE], [CSA], [CROSSREF]
- Kavanagh N., Corrigan O. I. Swelling and erosion properties of hydroxypropylmethylcellulose (Hypromellose) matrices—influence of agitation and dissolution medium composition. Int. J. Pharm. 2004; 279(1–2)141–152, [INFOTRIEVE], [CSA], [CROSSREF]
- Khan G. M., Zhu J. B. Studies on drug release kinetics from ibuprofen-carbomer hydrophilic matrix tablets: influence of co-excipients on release rate of the drug. J. Control. Release. 1999; 57: 197–203, [INFOTRIEVE], [CSA], [CROSSREF]
- Kibbe A. H. Handbook of Pharmaceutical Excipients 3rd. Informa UK Ltd, Washington, DC 2000
- Kim H., Fassihi R. Application of binary polymer system in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics. J. Pharm. Sci. 1997; 86(3)323–328, [INFOTRIEVE], [CSA], [CROSSREF]
- Lapidus H., Lordi N. J. Drug release from compressed hydrophilic matrices. J. Pharm. Sci. 1968; 57: 1292–1301, [INFOTRIEVE], [CSA]
- Li S., Lin S., Chien Y. W., Daggy B. P., Mirchandani H. L. Statistical optimization of gastric floating system for oral controlled delivery of calcium. AAPS Pharm. Sci. Tech. 2001; 2(1), article 1.[CSA]
- Li S., Lin S., Daggy B. P., Marchandani H. L., Chien Y. W. Effect of formulation variables on the floating properties of gastric floating drug delivery system. Drug Dev. Ind. Pharm. 2002; 28(7)783–793, [INFOTRIEVE], [CSA], [CROSSREF]
- López-Solis J., Villafuerte-Robles L. Effect of disintegrants with different hygroscopicity on dissolution of Norfloxacin/Pharmatose DCL11 tablets. Int. J. Pharm. 216 2001; 127–135, [CSA], [CROSSREF]
- Mandal T. K. The influence of binding solvents on drug release from hydroxypropyl methylcellulose tablets. Drug Dev. Ind. Pharm. 1995; 21: 1389–1397, [CSA]
- Martínez-González I., Villafuerte-Robles L. Effect of varying the restriction degree of 4-aminopyridine release from HPMC matrices on the mechanism controlling the process. Int. J. Pharm. 2003a; 257: 253–264, [CSA], [CROSSREF]
- Martínez-González I., Villafuerte-Robles L. Influence of enteric citric acid on the release profile of 4-aminopyridine from HPMC matrix tablets. Int. J. Pharm. 2003b; 251(1–2)183–193, [CSA]
- Martínez-González I., Villafuerte-Robles L. Influence of enteric lactose on the release profile of 4-aminopyridine from HPMC matrix tablets. Pharm. Dev. Tech. 2004; 9(2)145–153, [CSA], [CROSSREF]
- Ranga Rao K. V., Padmalatha Devi K., Buri P. Cellulose matrices for zero-order release of soluble drugs. Drug Dev. Ind. Pharm. 1988; 14(15–17)2299–2320, [CSA]
- Rinaki E., Valsami G., Macheras P. The power law can describe the “entire” drug release curve from HPMC-based matrix tablets: a hypothesis. Int. J. Pharm. 2003; 255: 199–207, [INFOTRIEVE], [CSA], [CROSSREF]
- Risbud M. V., Hardikar A. A., Bhat S. V., Bhonde R. R. pH-sensitive freeze dried chitosan-polyvinyl pyrrolidone hydrogels as controlled release system for antibiotic delivery. J. Control. Release 2000; 68: 23–30, [INFOTRIEVE], [CSA], [CROSSREF]
- Sheth P. R., Tossounian J. L., U.S. Patent No. 4,140,755, 1979, (pp. 1–2). Washington, DC: U.S. Patent and Trademark Office
- Shott H. Kinetics of swelling of polymers and their gels. J. Pharm. Sci. 1992; 81(5)467–470, [CSA]
- Singh B. N., Kim K. H. Floating drug delivery systems: An approach to oral controlled drug delivery via gastric retention. J. Control. Release 2000; 63: 235–259, [INFOTRIEVE], [CSA], [CROSSREF]
- Vigoreaux V., Ghaly E. S. Fickian and relaxational contribution quantification of drug release in a swellable hydrophilic polymer matrix. Drug Dev. Ind. Pharm. 1994; 20(16)2519–2526, [CSA]
- Wu Y., Fassihi R. Stability of metronidazole, tetracycline HCl and famotidine alone and in combination. Int. J. Pharm. 2005; 290: 1–13, [INFOTRIEVE], [CSA], [CROSSREF]
- Xu G., Groves M. J. Effect of FITC-dextran molecular weight on its release from floating cetyl alcohol and HPMC tablets. J. Pharm. Pharmacol 2001; 53: 49–55, [INFOTRIEVE], [CSA], [CROSSREF]
- Yang L., Eshraghi J., Fassihi R. A new intragastric delivery system for the treatment of Helicobacter pylori associated gastric ulcer: in vitro evaluation. J. Control. Release 1999; 57: 215–222, [INFOTRIEVE], [CSA], [CROSSREF]